Citation

87 FR 27644

Multiple canonical documents share this first-page citation.

Agency Information Collection Activities; Proposed Collection; Comment Request; Warning Plans for Smokeless Tobacco Products Monday, May 9, 2022 87 FR 27644
Celgene Corporation and Teva Pharmaceutical Industries Ltd.; Withdrawal of Approval of Peripheral T-Cell Lymphoma Indication for ISTODAX (Romidepsin) for Injection and Romidepsin Injection Monday, May 9, 2022 87 FR 27644